CHICAGO -- Coming this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring ...

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...

Several studies have been done on the myriad list of side effects that come from popular weight loss drugs.  A new study ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or ...

In the past year, treatments such as Wegovy, Mounjaro and Zepbound have become household names. But there are many questions ...

The results of this cohort study suggest that semaglutide use was associated with an increased risk of nonarteritic anterior ischemic ...

Patients taking compounded weight loss drugs from online pharmacies share what it's like — and they couldn't go the ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...